Caption Shown here are the pathological hallmarks of Alzheimer's disease, beta-amyloid plaques (brown spots), as seen both in brain and retinal tissues from deceased patients, as described in the ...

Low-level light therapy, also called photobiomodulation (PBM), has emerged as a promising approach to Alzheimer's treatment, ...

They also say that their graphene grid method could be used to determine the structures of other small and unstable proteins -- including the amyloid-beta peptide that builds up in the brain in ...

Dr Berg explained that some individuals might notice amyloid-beta plaquing on the retina, which can lead to difficulties in distinguishing shades of grey and other colours. Studies suggest that ...

Beta-amyloid peptide toxicity has also been implicated in the development of retinal ganglion cell apoptosis in glaucoma. Another arm of So’s brain research studies the anti-inflammatory effects ...

The aggregation of these proteins, which are known as "amyloid-beta," give rise to a chain of events that ultimately harm neurons and lead to their loss. "Alzheimer's disease involves a complex ...

Neuroimaging studies performed when the man was 73 years old revealed that he had elevated levels of amyloid beta plaques in his cortex compared to other individuals with the PSEN1-E280A mutation.